[DISCLOSURE] DIO (039840) said on Aug. 18 it has decided to invest 278.5 million won (US$251,800) to build a joint corporation, DIO FO Medical Instrument, in cooperation with Shanghai Foshion Medical Systems, a local dental company in Shanghai. It will own 51 percent stake in the company.
The investment cost is equivalent to 0.33 percent of the DIO’s equity capital.
The investment cost is equivalent to 0.33 percent of the DIO’s equity capital.